MCRB - Seres Therapeutics GAAP EPS of -$0.27 beats by $0.07
2024-05-08 07:26:02 ET
More on Seres Therapeutics
- Seres Therapeutics GAAP EPS of -$0.89 beats by $0.10, revenue of $126.33M beats by $0.23M
- Seeking Alpha’s Quant Rating on Seres Therapeutics
- Historical earnings data for Seres Therapeutics
- Financial information for Seres Therapeutics